Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas

Radiotherapy and Oncology

Volumn 72, Issue 3, 2004, Pages 275-282

  Eriksen, Jesper G ^a   Buffa, Francesca M ^b   Alsner, Jan ^a   Steiniche, Torben ^a   Bentzen, Søren M ^b   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Cluster analysis; Head and neck; Local control; Radiotherapy; Squamous cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FORMALDEHYDE; KI 67 ANTIGEN; PARAFFIN; PROTEIN BCL 2; PROTEIN P53; UVOMORULIN;

ALGORITHM; BAYES THEOREM; CANCER SURVIVAL; CLUSTER ANALYSIS; CONFERENCE PAPER; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; WILD TYPE;

ALGORITHMS; CADHERINS; CARCINOMA, SQUAMOUS CELL; GLOTTIS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 4644316645     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.07.014     Document Type: Conference Paper

References (24)

1. H.R. Withers, J.M. Taylor, and B. Maciejewski The hazard of accelerated tumor clonogen repopulation during radiotherapy Acta Oncol 27 1988 131 146
2. J. Overgaard, H.S. Hansen, and L. Specht Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 362 2003 933 940
3. C. Grau, H.S. Hansen, and L. Specht Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 57 2003 S154
4. K.K. Fu, T.F. Pajak, and A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
5. A. Hliniak, B. Gwiazdowska, and Z. Szutkowski A multicentre randomized/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a 1 week shortening overall time Radiother Oncol 62 2002 1 10
6. K. Skladowski, B. Maciejewski, and M. Golen Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity Radiother Oncol 55 2000 101 110
7. S.M. Jackson, L.M. Weir, and J.H. Hay A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer Radiother Oncol 43 1997 39 46
8. O. Hansen, J. Overgaard, and H.S. Hansen Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation Radiother Oncol 43 1997 47 51
9. J. Overgaard, H.S. Hansen, and M. Overgaard Importance of overall treatment time for the outcome of radiotherapy in head and neck carcinoma. Experience from the Danish Head and Neck Cancer Study H.D. Kogelnik F. Sedelmayer Progress in Radio-Oncology IV 1998 Monduzzi Editore Bologna 743 752
10. G. Anneroth, J. Batsakis, and M. Luna Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas Scand J Dent Res 95 1987 229 249
11. F.M. Buffa, S.M. Bentzen, and F.M. Daley Molecular marker profiles predict loco-regional control of head and neck squamous cell carcinoma in a randomised trial of continuous hyperfractionated accelerated radiotherapy (CHART) Clin Cancer Res 10 2004 3745 3754
12. C. Lund, H. Sogaard, and K. Jorgensen Histological grading of epidermoid carcinomas in the head and neck Dan Med Bull 24 1977 162 166
13. J.G. Eriksen, T. Steiniche, and J. Alsner The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck Int J Radiat Oncol Biol Phys 2004 561 566
14. J. Alsner Isolation and sequencing of heteroduplex fragments from DHPLC analysis of somatic, low-frequency mutations K.H. Hecker Genetic variance detection. Nuts and bolts of DHPLC in genomics 2003 DNA Press Eagleville, PA 163 173
15. G.D. Wilson, M.I. Saunders, and S. Dische Bcl-2 expression in head and neck cancer: an enigmatic prognostic marker Int J Radiat Oncol Biol Phys 49 2001 435 441
16. B.G. Haffty, and P.M. Glazer Molecular markers in clinical radiation oncology Oncogene 22 2003 5915 5925
17. C.H. Chung, J.S. Parker, and G. Karaca Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression Cancer Cell 5 2004 489 500
18. S. Dische, M. Saunders, and A. Barrett A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer Radiother Oncol 44 1997 123 136
19. S.M. Huang, J.M. Bock, and P.M. Harari Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck Cancer Res 59 1999 1935 1940
20. R.K. Schmidt-Ullrich, R.B. Mikkelsen, and P. Dent Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation Oncogene 15 1997 1191 1197
21. K.J. Hodivala, and F.M. Watt Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation J Cell Biol 124 1994 589 600
22. Z. Lu, S. Ghosh, and Z. Wang Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion Cancer Cell 4 2003 499 515
23. G. Deeb, J. Wang, and N. Ramnath Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry Mod Pathol 17 2004 430 439
24. S. Inada, T. Koto, and K. Futami Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor) Surg Today 29 1999 493 503